A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Heart Rhythm

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.hrthm.2012.09.053PMID 23010577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Partially Dominant Mutant Channel Defect Corresponding with Intermediate LQT2 Phenotype

  2012cited by this paper
• Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.

  2012cited by this paper
• A KCR1 variant implicated in susceptibility to the long QT syndrome.

  2011cited by this paper
• Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice

  2010cited by this paper
• Genotype-phenotype aspects of type 2 long QT syndrome.

  2009cited by this paper
• Misdiagnosis of long QT syndrome as epilepsy at first presentation.

  2009cited by this paper
• Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome

  2009cited by this paper
• HERG‐F463L POTASSIUM CHANNELS LINKED TO LONG QT SYNDROME REDUCE IKr CURRENT BY A TRAFFICKING‐DEFICIENT MECHANISM

  2009cited by this paper
• Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines.

  2009cited by this paper
• Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy

  2009cited by this paper
• A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope.

  2008cited by this paper
• HERG is protected from pharmacological block by alpha-1,2-glucosyltransferase function.

  2007cited by this paper
• HERG Is Protected from Pharmacological Block by α-1,2-Glucosyltransferase Function*

  2007cited by this paper
• Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.

  2007cited by this paper
• Long QT syndrome: reduced repolarization reserve and the genetic link

  2006cited by this paper
• Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism

  2006cited by this paper
• Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification.

  2006cited by this paper
• Genetics of acquired long QT syndrome.

  2005cited by this paper
• Pharmacological rescue of trafficking defective HERG channels formed by coassembly of wild-type and long QT mutant N470D subunits.

  2004cited by this paper
• Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.

  2004cited by this paper
• IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines

  2003cited by this paper
• Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C*

  2003cited by this paper
• Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel

  2002cited by this paper
• Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.

  2002cited by this paper
• Electrocardiographic Prediction of Abnormal Genotype in Congenital Long QT Syndrome: Experience in 101 Related Family Members

  2001cited by this paper
• Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

  2001cited by this paper
• A sensitive mechanism for cation modulation of potassium current

  2000cited by this paper
• Long QT Syndrome:

  2000cited by this paper
• Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2

  2000cited by this paper
• Correction of Defective Protein Trafficking of a Mutant HERG Potassium Channel in Human Long QT Syndrome

  1999cited by this paper
• Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation.

  1998cited by this paper
• Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.

  1997cited by this paper
• Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.

  1996cited by this paper
• Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.

  1996cited by this paper
• The Long QT Syndrome: Prospective Longitudinal Study of 328 Families

  1991cited by this paper

• Lumacaftor and fexofenadine prevent donepezil-induced LQTS via PHE656-mediated hERG chaperoning.

  2026cites this paper
• KCNH2‐L693P Causes Long QT Syndrome Type 2 Through hERG Channel Dysfunction: Functional Validation of a Variant of Uncertain Significance

  2025cites this paper
• The utility of zebrafish cardiac arrhythmia model to predict the pathogenicity of KCNQ1 variants.

  2023cites this paper
• Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K+ channels: Validation with hERG

  2022influential citation
• Genomic and Non-Genomic Regulatory Mechanisms of the Cardiac Sodium Channel in Cardiac Arrhythmias

  2022cites this paper
• A Soluble Epoxide Hydrolase Inhibitor Upregulated KCNJ12 and KCNIP2 by Downregulating MicroRNA-29 in a Mouse Model of Myocardial Infarction.

  2020cites this paper
• Reduced hybrid/complex N-glycosylation disrupts cardiac electrical signaling and calcium handling in a model of dilated cardiomyopathy.

  2019cites this paper
• Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction

  2018cites this paper
• Functional analysis of KCNH2 gene mutations of type 2 long QT syndrome in larval zebrafish using microscopy and electrocardiography

  2018cites this paper
• Bestrophin 1 and retinal disease.

  2017cites this paper
• Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.

  2016cites this paper
• Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks

  2016cites this paper
• Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy

  2016cites this paper
• The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.

  2015cites this paper
• Genetics of long-QT syndrome

  2015cites this paper
• Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation

  2015cites this paper
• Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects

  2014cites this paper
• Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects

  2014cites this paper
• Mutation location matters in long QT syndrome type 2 (but behavior matters more).

  2013cites this paper
• Is exercise-related QT interval shortening with a peaked T wave a specific electrocardiographic finding of pheochromocytoma?

  2013cites this paper
• Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation

  year unknowncites this paper